$30M doesn’t just move the needle, it rewires the machine. ExaCare AI just closed its Series A, led by Insight Partners with Foundation Capital, Bienville Capital, and a few post acute care operators joining the charge. Founded in 2022 by Laird Russell (Co-Founder & CEO) and Benjamin Willox (Co-Founder & CTO), this NYC-based startup is taking the chaos of post-acute operations and turning it into structured intelligence that actually works for care teams instead of wearing them out.
This one hits different because ExaCare AI isn’t built from theory, it’s built from lived experience. Laird Russell spent 3.5 years recovering from a traumatic brain injury, navigating the labyrinth of medical care as a patient before deciding the system needed a brain of its own. Partnering with Benjamin Willox, a technical mind with a 4.0 from The University of British Columbia and serious chops in AI, they built a platform that eats referral documents for breakfast and spits out clarity in minutes.
With $30M now fueling their climb, ExaCare AI has processed 2.9M referrals and reviewed 21M+ documents across 1,500+ post-acute facilities, including heavy hitters like National Healthcare Associates, Journey Healthcare, Ignite Medical Resorts, Monarch Healthcare Management, and Majestic Care. The post-acute market, valued at $472.9B in 2024 and growing at 6.3% annually, isn’t small potatoes. It’s a sector begging for precision, and ExaCare’s tech delivers it in spades.
The core play? AI models tuned to read the messy reality of care: referral packets, payer rules, and clinical red flags that make or break an admission. Admissions Intelligence powers faster triage. Clinical Risk Assessment keeps patient complexity transparent. Financial Screening optimizes reimbursement under PDPM. The integration game is tight, Epic Care Link, PointClickCare, and soon, a full AI Agent Suite running admissions, reimbursement, documentation, and survey readiness like a digital pit crew for healthcare operations.
Led by George Mathew of Insight Partners, former CEO of Kespry and President & COO of Alteryx, this round isn’t just capital, it’s credibility. Foundation Capital and Bienville Capital saw it early; now the rocket’s cleared the tower. The $36.5M raised to date will expand engineering, product, and customer support teams from New York to Toronto, hiring talent from Amazon, Google, and beyond.
In a market crushed by staffing shortages and margin pressure, ExaCare AI isn’t chasing trends, it’s building tools that let humans focus on care while AI handles the grind. When you can turn operational friction into data-driven momentum, that’s not automation, it’s liberation.
